GL1X · GenesisL1 explorer

MolNFT v1 · #71677 · protein

Banadd in complex with inhibitor 1_02

3MLA · Nicotinate-nucleotide adenylyltransferase: “Banadd in complex with inhibitor 1_02”. X-ray diffraction, 1 ligand (JJZ), 2 pockets (best druggability 0.88). MolNFT v1 #71677 on GenesisL1: 3D structure, binding sites and pockets in…

PDB
3MLA
Type
protein
Length
372 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Nicotinate-nucleotide adenylyltransferase
EC
2.7.7.18
UniProt
C3L5T6
Ligands
JJZ
Pockets
2 · best druggability 0.88

Structure

x-ray diffraction · 2 distinct chains · 37% helix, 19% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ANicotinate-nucleotide adenylyltransferase (EC 2.7.7.18)protein18837% helix, 20% strandC3L5T6
BNicotinate-nucleotide adenylyltransferase (EC 2.7.7.18)protein18438% helix, 19% strandC3L5T6

Ligands and binding sites

  • JJZ · 4-[2-(anthracen-9-ylmethylidene)hydrazino]-N-(3-chlorophenyl)-4-oxobutanamide · ligand · chains A, B
  • FMT · Formic acid · additive · 5 copies · chains A, B
  • DMS · Dimethyl sulfoxide · additive · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
111950.880.89120JJZ, FMT
21440.450.7623empty

Interfaces

1 interface between chains.

  • A–B · 1857 Ų buried · 27 hydrogen bonds · protein-protein

Compared structures

  • 3MLA · BaNadD in complex with inhibitor 1_02 · the same entry in another collection · chain A against A, TM-score 1.00
  • C3L5T6 · AlphaFold monomer V2.0 prediction for probable nicotinate-nucleotide adenylyltransferase… · a predicted model of the same protein · chain B against A, TM-score 0.94

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.